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Abstract
Protection against malaria often decays in the absence of infection, suggesting that protective immunological memory
depends on stimulation. Here we have used CD4
+ T cells from a transgenic mouse carrying a T cell receptor specific for a
malaria protein, Merozoite Surface Protein-1, to investigate memory in a Plasmodium chabaudi infection. CD4
+ memory T
cells (CD44
hiIL-7Ra
+) developed during the chronic infection, and were readily distinguishable from effector (CD62L
loIL-
7Ra
2) cells in acute infection. On the basis of cell surface phenotype, we classified memory CD4
+ T cells into three subsets:
central memory, and early and late effector memory cells, and found that early effector memory cells (CD62L
loCD27
+)
dominated the chronic infection. We demonstrate a linear pathway of differentiation from central memory to early and then
late effector memory cells. In adoptive transfer, CD44
hi memory cells from chronically infected mice were more effective at
delaying and reducing parasitemia and pathology than memory cells from drug-treated mice without chronic infection, and
contained a greater proportion of effector cells producing IFN-c and TNFa, which may have contributed to the enhanced
protection. These findings may explain the observation that in humans with chronic malaria, activated effector memory cells
are best maintained in conditions of repeated exposure.
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Introduction
Protective immunity to malaria develops only after repeated
infections; although protection from homologous infection [1] and
lethal malaria occurs after one to two infections [2]. Immunity to
infection can persist for years; however, clinical immunity can be
lost on emigration away from endemic areas, and high levels of
exposure lead to lower disease prevalence than lower exposure [3].
Furthermore, human vaccine trials and mouse models have shown
that immunity decays both with time after vaccination and that
treatment of infection reduces protection [4,5,6]. These observa-
tions suggest that continuous exposure to the parasite may be
required for the maintenance of immunological protection from
malaria, as has also been suggested in Leishmania and other chronic
infections [7,8]. Recent work with Plasmodium chabaudi demon-
strated that the decay of protection is replicated in mouse models
and that this may be determined by a decay in memory T cell
(Tmem) function [5].
Adaptive immunity to infection develops by accrual of antigen-
experienced memory cells. In the absence of chronic infection,
resting, antigen-independent memory T cells reside in secondary
lymphoid organs; however, in chronic infection, memory cells and
effector cells may be continually generated [9], and may even expand
the memory cell pool [10]. Central memory T cells (Tcm, [11]),
definedbyhighlevelsofexpressionofCD62L,havebeenshowntobe
protective in various infections [12,13]. However, infection with
Plasmodium liver-stages and other chronic infections have been shown
to primarily produce effector memory and effector CD8
+ Tc e l l s
[14,15], which are also protective [12,16]. In humans, CD8+ effector
memory (Tem) cells have been subdivided with activation markers
into early and late subsets, with different subsets predominating in
different infections,however,it has not yet been determined how they
are derived [17,18,19]. In some chronic infections where high
pathogen loads persist, such as HIV and LCMV, chronic stimulation
leads to functional impairment or exhaustion of CD8
+ Tc e l l s ,a n d
production of IL-10, which slows clearance of the pathogen [20],
while in other infections, such as HCV, virus-specific CD8
+ memory
T cells actually accumulate [9,21].
While there have been relatively few studies of CD4
+ T cell
memory in malaria, it is known that immunity to the blood stages
of Plasmodium is dependent on both CD4
+ T cells and B cells [22],
and the presence of Plasmodium-specific CD4+ T cells, in some
cases, has been shown to correlate with clinical immunity [23].
However, it has been shown that P. yoelii and P. berghei infections
can lead to deletion of specific CD4
+ T cells generated by
vaccination [24], and a recent study showed that protective CD4
+
T cell memory decays after 6.5 months in P. chabaudi infection [5],
suggesting some impairment of long-lived immunological memory
in blood-stage malaria infections. Therefore it is critical to
understand more about the generation and maintenance of
memory T cells in malaria to improve our capacity to generate
long-lived protection by vaccination.
Here we have investigated the development of Plasmodium-specific
CD4
+ T cells using a transgenic mouse with CD4
+ T cells specific for
PLoS Pathogens | www.plospathogens.org 1 November 2010 | Volume 6 | Issue 11 | e1001208a peptide within Merozoite Surface Protein-1 (MSP1, [25]), the B5 T
cell receptor Transgenic (B5 TCR Tg). MSP1 is expressed on the
surface of merozoites and is a candidate antigen for inclusion in a
blood-stage malaria vaccine. We establish that a heterogeneous
memory CD4
+ T cell population develops after a primary infection,
and is composed predominantly of early effector memory T cells
(TemE). We demonstrate a pathway of differentiation from central
memory to early and then late effector memory CD4 T cells by
adoptively transferring these three subsets into P. chabaudi-infected
RAGu mice. We also show that upon adoptive transfer, memory
CD4
+ T cells from chronically infected mice delay the onset of
parasitemia and protect better against pathology than rested memory
cells, suggesting that continuous stimulation enhances the effector
function and protective capacity of memory T cells in malaria,
correlating with their enhanced Th1 cytokine production. While we
have previously shown the importance of B cells and antibodies in
clearance of primary infection, the current studies suggest a role for
cytokine production by memory T cells in long-term protection. This
may be one of the reasons why people are better protected against
malaria when they are re-infected frequently.
Results
In order to identify malaria-specific CD4
+ T memory cells during
malaria, we have followed the response of P. chabaudi-specific
transgenic CD4
+ T cells, which carry a TCR recognising a peptide
of Merozoite Surface Protein-1 (B5 Tg, [25]), throughout a blood-
stage infection of P. chabaudi in mice. This infection is characterised
by an acute phase with a peak parasitemia 8–10 days post-infection
of approximately 25% infected erythrocytes. After the acute phase,
parasitemia is reduced but not eliminated and can persist as a low-
grade chronic infection for up to 3 months [6]. Purified naı ¨ve
(CD44
loCD25
2), MSP1-specific B5 TCR Tg CD4
+ T cells
(Thy1.2
+) were labelled with CFSE and injected into BALB/c
Thy1.1 mice (2610
6 per mouse). The recipient mice were infected
with P. chabaudi the following day, and the transferred B5 Tg T cells
were followed by flow cytometry for 60 days after infection.
The acute P. chabaudi infection lasting about 20 days, and the
subsequent low-level chronic infection may result in the contin-
uous generation of effector cells, as has been reported in other
persistent infections [9,21,26]. Therefore, we utilized multiparam-
eter flow cytometry and the activation and memory markers,
CD44, CD43, CD27, IL-7Ra and CD62L [16,27,28] to
distinguish between CD4
+ effector and memory subsets. At day
9 of infection, the majority of Tg cells had divided (CFSE
neg,
FACS gating showing level of CD44 expression correlating with
cell division is shown in Figure S1), and were defined as effector
cells (Teff) CD62L
lo, IL-7Ra
2, CD43
+, and CD27
2, and CD44
int
(Figure 1A). Flow cytometry data gated on CD4
+Thy1.2
+
CFSE
neg divided B5 Tg cells were collected at several time-points
during the infection, and subjected to boolean gating analysis,
which distributed them into the 32 possible subsets generated by
testing every possible combination of the 5 activation markers.
This is shown in the histogram in Figure 1B, where the
percentage of the divided B5 Tg CD4
+ T cells falling into each
subset is illustrated. Strikingly, this unbiased analysis identified
effector cells as CD62L
loIL-7Ra
2 during the acute parasitemia at
day 9, while memory cells were easily distinguished by their
upregulation of IL-7Ra, as seen in the majority of divided,
CFSE
neg B5 Tg cells by day 60, which fell into both the effector
(Tem) and central (Tcm) memory categories as indicated by their
expression of CD62L. Various subsets could be seen within these
major populations, and the other three markers, CD44, CD43,
CD27, were used to determine the overall activation status of the
cells. By grouping subsets based on the number of activation
markers they express, we constructed pie charts to demonstrate
graphically how activated the MSP1-specific cells were throughout
the P. chabaudi infection (Figure 1C). More than 80% of the Tg T
cells expressed markers of activation at day 9, and interestingly,
many malaria-specific cells remained activated even at day 21,
when the parasite was cleared to below 0.01% of erythrocytes
infected. At day 45, the activation status of the cells appeared to
have stabilized, so that even at day 60, 25% of the cells maintained
three or more markers of activation. This suggests that a large
proportion of the MSP1-specific Tg T cells that persisted late into
the chronic phase of infection remained considerably activated
and did not become resting or central memory cells in this time.
In these studies, when 2610
6 B5 Tg CD4+ T cells were
transferred into the recipient mice, more than 70% of the specific
cells divided, as shown in Figure 1A. We focused on divided cells
(CFSE
neg) as they represent the specific response, however, it is
possible that transfer of this number of cells may have led to non-
physiological responses [29]. We therefore transferred fewer T
cells (Figure S2A) and were able to detect them by enriching
Thy1.2
+ cells before analysis and utilizing the enhanced signal to
noise ratio of double staining to detect the small numbers of cells.
We could see expansion of 30,000 or 5,000 naı ¨ve purified T cells
at the peak of infection (day 6) in the spleen, with some cells still
remaining undivided (Figure S2B), as in the transfer of 2610
6
cells. By day 60 more cells divided when fewer cells were
transferred, as previously reported, and there was a similar
distribution of memory T cell subsets as with more cells. When less
than 10
6 cells were transferred, less than 50 B5 cells were collected
at day 60 necessitating concatenation of the FACS data for
visualization. Transferring more cells allowed us to analyze the
data from each mouse separately, concatenating only for display.
Therefore it was not possible to carry out further experiments with
lower numbers of cells and attain statistically meaningful data.
When few cells are transferred no transferred cells are detectable
in uninfected mice after two months, consistent with the data of
others [29], and suggesting that the transgenic cells are not
expanding in a malaria-antigen-independent manner. The
approach of transferring 2610
6 cells was further validated by
the consistency of data from 5 individual mice in Figure S3.
Importantly, transfer of 2610
6 cells resulted in a physiological
response, in that the small fraction that survives (0.01%) was the
same proportion as MSP-1 responsive T cells in wild-type mice, as
Author Summary
Protective immunity against malaria develops only after
several infections and can be lost on leaving an area in
which malaria is transmitted. This suggests that the
chronic infection may maintain the protective immune
response. In this paper we have used a mouse model of a
blood-stage malaria infection to examine the memory
response of CD4
+ T cells during chronic infection. These T
cells are required for protective immunity, and also play a
part in the inflammatory response that gives rise to malaria
disease. Understanding what constitutes a protective CD4
+
T cell may help us design more protective vaccines. We
show that these memory CD4
+ T cells persist in an
activated state, produce the inflammatory cytokines TNFa
and IFN-c, and are more protective than ‘‘resting’’ memory
CD4
+ T cells obtained from mice in which the infection has
been eliminated. This may explain why people are better
protected against malaria disease when they are infected
frequently.
CD4 T Cell Memory to Mouse Malaria
PLoS Pathogens | www.plospathogens.org 2 November 2010 | Volume 6 | Issue 11 | e1001208Figure 1. Memory T cells with an activated phenotype can be distinguished from effector T cells. Sorted Naı ¨ve (CD44
loCD25
2), CFSE-
labelled B5 T cells (2610
6) were seeded into congenic Thy1.1
+ mice. Mice were infected with 10
5 P. chabaudi iRBC, sacrificed and splenocytes stained
with anti-CD4, Thy1.2 and activation markers CD44, CD43, CD27, IL7Ra and CD62L at different times post infection. A) Divided B5 T cells (CFSE
neg
Thy1.2
+, left plot and histogram) were analyzed for expression of the activation markers on day 9 post-infection by multiparameter flow cytometry.
Histograms show gating for the activation markers. CFSE
neg B5 Tg effector T cells (Teff) are CD44
int-hi, IL-7Ra
2, CD62L
lo, and can be CD43
+/2, and
CD27
+/2. B) CFSE
neg (divided) B5 Tg T cells were boolean gated into 32 possible subsets based on their expression all five markers. The percentage of
cells expressing each combination of markers for all of the subsets at day 9 (white bars) and day 60 (black bars) are shown in the histograms. Boxes
below indicate the marker listed to the left. The blue box on the right indicates the group with none of the markers of activation. C) CFSE
neg Tg cells
were pooled into groups according to the number of activation markers expressed (color coded for 0–5 markers of activation as shown in the panel
on the left, with colors ranging from blue: no activation markers; to purple, 5 activation markers), and the percentage of cells in each group is shown
in a pie chart to indicate the relative activation state on a given day post-infection. A representative experiment of 3 performed is shown. The values
shown are for 2–5 mice at each time point, cytometry data were concatenated. Experiment was repeated twice with similar results.
doi:10.1371/journal.ppat.1001208.g001
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of CD4
+ T cells from BALB/c mice respond to B5-containing
fragment of MSP-1 after ten weeks of P. chabaudi infection [30]).
Effector CD4
+ T cells persist in P. chabaudi infection and
effector memory cells predominate
Effector and memory cells amongst the transferred Tg CD4 T
cells were further analyzed using the expression profile, IL-
7Ra
2CD62L
lo, described above for effector cells (Figure 2A) and
CD44
hiIL-7Ra
+ (Figure 2B, left contour plot) for memory T
cells. As shown graphically in Figure 2C, at day 9 of infection,
these effector CD4
+ T cells accounted for approximately 75–80%
of the MSP1-specific Tg T cell population, were still a substantial
proportion of the total B5 T cell population at day 21, and despite
low parasitemias, some even persist to day 60. CD44
hiIL-7Ra
+
CD4 memory cells were present by day 21 when parasitemia is
very low, but memory cells did not become the dominant
population until day 45. This is important as it suggests that the
memory phase where memory T cells dominate over effector cells
may be delayed by chronic low-level infection.
Human CD8
+ effector memory T cells observed in various virus
infections have been subdivided further into ‘‘early’’, ‘‘intermedi-
ate’’ and ‘‘late’’ based on differential expression of CD28 and CD27
[18]. We wanted to determine whether the CD44
hiIL-7Ra
+ Tg
CD4+ memory cells in P. chabaudi infection also contained
subpopulations suggesting differential stimulation, or stages of
differentiation. CD28 could not be used in our experiments as a
marker for further subdivision of Tem subsets, as expression of this
molecule is not up-regulated on mouse T cells with activation
[17,18]. We therefore defined subsets within the IL-7Ra
+ memory
Tg cellsusing CD27 and CD62L.CFSE
neg (divided)B5 T cellswere
gated on CD44
hiIL-7Ra
+ memory cells and expression of CD27,
and CD62L analyzed on these cells to show the distribution of
central and effector memory T cells (Figure 2D, left contour plot).
There were two effector memory subsets, which correlated with
early and late effector memory (TemE, TemL). Thisanalysis on day
60 post-infection showed that TemE B5 Tg cells (CD27
+, CD62L
2)
dominatedtheresponse(Figure2D,graph).Both the proportion of
CD44
hi IL-7Ra
+ memory T cells and the subsets defined by CD27
and CD62L remained similar on days 45 and 60 (data not shown).
We also observed the development and trafficking of memory T
cells in the lymph nodes and saw both central and effector memory
cells, while liver contained only effector memory cells (Figure S4).
Memory cells were also observed in the bone marrow in small
numbers (data not shown).
In many, but not all, persisting infections, T cells have been
shown to express inhibitory receptors such as PD-1 (CD279) and
KLRG1. These correlate with dysfunction of the T cells called
exhaustion, and can regulate pathogenic responses [31,32].
However, although P. chabaudi infection in mice has a prolonged
acute parasitemia and a long chronic phase, few PD-1
+ effector
(Figure 2E) Tg CD4
+ T cells (all CD62L
lo, maximum of 5.7% at
day 21) were transiently present, and no KLRG-1+ cells were
observed (data not shown). This suggests that terminal differenti-
ation ofeffectorcellsistakingplacenormally,and thatexhaustionof
CD4
+ T cells is not a problem in this malaria infection, but the data
show the memory cells remain in an activated state. Therefore, we
investigated the pathway of differentiation that leads to this state.
Differentiation of malaria-specific CD4
+ T cell memory
subsets
As early (CD27
+ CD62L
2) and late (CD27
2 CD62L
2) effector
memory cell subsets (TemE and TemL) have not previously been
studied in mouse CD4
+ T cell populations, we investigated the
cytokine profiles and differentiation potential of each of the three
subsets in this P. chabaudi infection. Using TAPI-2, an inhibitor of
the metalloproteases that cleave CD62L and TNFa [33], we were
able to perform intracellular cytokine staining on memory T cells at
day 60 post-infection whilst maintaining expression of CD62L.
MSP1-specific Tcm, TemE and TemL cells were identified using
CD44, CD62L and CD27, as described above, and their IFN-c and
IL-10 profiles analyzed (Figure 3A). Interestingly, while Tcm and
TemL subsets contained small populations of IFN-c
+ cells and few
IL-10
+ cells; 52% (+/24.1 SEM) of TemE cells made either IL-10
or IFN-c, and 14% (+/22.9 SEM) made both cytokines. Despite
producing little IFN-c or IL-10, almost 70% CD44
hiCD62L
hi Tcm
cells were capable of making TNF or IL-2. Tem on the other hand,
contained fewer TNFand IL-2positive cells(Figure 3B). It wasnot
technically possible to analyse three cytokines together and still have
sufficient available parameters to subdivide the Tem cell subsets
further, or to include IL-7Ra to distinguish effector memory cells
from effector cells (,10% on day 60).
In order to determine how the three memory T cell subsets
relate to each other and to effector cells, and how they differentiate
and survive in the face of constant exposure to infection, transfer
experiments with the CD44
hiIL-7Ra
+ memory cell subsets were
undertaken. We could not magnetically sort Thy1.2+ Tg cells
from the spleen at day 60 due to hemozoin, an insoluble iron-
containing catabolite of hemoglobin that makes phagocytes
magnetic. Therefore, to analyze memory T cell differentiation
and protection in vivo, we generated memory cells to test by
infecting the B5 transgenic mouse. Interestingly, although 80% of
the cells in this mouse are malaria-specific [25], a normal
percentage of effector cells and memory cells was generated
(Figure S5). Therefore, purified Tcm (CD62L
hi), TemE
(CD62L
loCD27
+), or TemL (CD62L
loCD27
2) from B5 TCR Tg
mice (Figure S6 shows the FACS profiles of the sorted cells), were
transferred into RAGu mice, that were then infected with P.
chabaudi. These experiments have not yet been done in the absence
of infection to ascertain the effect of homeostatic proliferation in
the RAGu recipients on the differentiation of memory T cells,
however, as antigen-induced proliferation is faster, it is likely that it
is the dominant pathway in chronic infection. The results showed
that not many Tcm cells were present on day 38. Although some
did survive and maintain their phenotype, they had largely
differentiated into effector memory and effector cells (Figure 3C,
Tcm); suggesting that Tcm have the intrinsic capacity to become
TemE, TemL and Teff when stimulated to divide. By contrast,
TemE had the capacity to expand and generate TemL and Teff
cells but not Tcm; while TemL only generated more TemL and
Teff cells. These data indicate that there is a linear differentiation
pathway from central to early effector to late effector memory, in
high-level chronic P.chabaudi infection (represented in Figure 3D),
and that all subsets can generate Teff.
Removal of the chronic P. chabaudi infection by
chloroquine treatment reduces protective capacity of
memory T cells
We have shown previously that chronically infected C57Bl/6
mice are more resistant to a second infection with the homologous
strain of P. chabaudi than mice whose chronic infection had been
eliminated with the anti-malarial drug chloroquine (CQ) [6]. This
was also the case for P. chabaudi infections in BALB/c mice
(Figure S7A). This suggests that memory B and T cells are
affected by chronic infection in such a way that they are more
effective when continually exposed to antigen.
CD4 T Cell Memory to Mouse Malaria
PLoS Pathogens | www.plospathogens.org 4 November 2010 | Volume 6 | Issue 11 | e1001208Figure 2. Effector CD4
+ T cells persist in P. chabaudi infection and early effector memory cells predominate. Naı ¨ve (CD44
loCD25
2), CFSE-
labelled B5 T cells (2610
6) were seeded into congenic Thy1.1
+ mice, which were then infected with 10
5 P. chabaudi iRBC. A) Divided B5 cells (CFSE
neg)
were analyzed for expression of CD62L and IL-7Ra to measure the percentages of Teff (CD62L
lo, IL-7Ra
2) in the spleen on day 9 (middle panel) and
day 60 (right panel). As an internal negative control, naı ¨ve cells (CFSE
+) from uninfected mice are shown (left panel). B) CD44
hiIL-7Ra
+ memory cells
are shown in the divided CFSE
neg population. C) Kinetics of appearance of Teff and Tmem as defined in A) and B) by percentage (left panel) or
number (610
3, right panel). D) Tmem were subdivided using CD62L and CD27 to measure central (Tcm, CD62L
hiCD27
+), and early effector memory
cells (TemE, CD62L
loCD27
+) as well as CD27
2 late effector memory T cells (TemL, CD62L
loCD27
2) shown here at day 60 of infection. The relative
proportions of Tcm, TemE and TemL of infection are shown in the right graph. E) PD-1 expression on B5 Transgenic CD4
+ T cells seeded in Thy1.1
congenic mice at different times during P. chabaudi infection. All PD-1
+ cells were CD62L
lo. Graphs represent the means and SEM of 2 to 5 mice per
time point. Plots show CD4
+Thy1.2
+CFSE
neg cells concatenated from 2–5 mice per time point (gated as shown in Figure 1A, raw data for B, D shown in
Figure S3). Experiments were repeated three times with similar results.
doi:10.1371/journal.ppat.1001208.g002
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contribute to this enhanced protection, we assessed the ability of
MSP1-specific CD4
+ T cells to confer protection in adoptive
transfer experiments into RAGu mice. As we found that the
individual memory T cell subsets in chronically infected mice did
not show differential protection, unfractionated Tg memory CD4
+
T cells (CD4
+CD44
hi) from chronically infected or from previously
infected and chloroquine-treated B5 transgenic mice, were
transferred into RAGu mice together with immune B cells, as
described previously [25,34].
We first verified that chloroquine treatment had resulted in loss
of the B5 antigen from the system, as well as eliminating the
chronic infection as described [6] (Figure S7B). CFSE-labelled
MSP-1-specific Tg CD4 T cells were injected into chronically
infected or infected and drug-cured mice at day 45 and 60 post-
infection, and recovered and analyzed after 3 days. Cell division of
the Tg cells, measured by CFSE levels, indicated whether the
MSP1 peptide was still being presented. Indeed, in the chronically
infected B5 mice, the B5 MSP1 peptide was still presented on
antigen-presenting cells at 45 and 60 days of infection as detected
by proliferation of CFSE-labelled MSP1-specific B5 Tg T cells. By
contrast, much less proliferation was observed in the Tg T cells
recovered from drug-cured mice (Figure S7B), suggesting that
after removal of parasites there was insufficient residual MSP1
antigen to stimulate Tg T cells and that we could consider these
memory cells as ‘‘resting’’.
After adoptive transfer of chronically simulated or rested CD4 T
cells into recipient mice, there were two clear major measurable
effects of these cell transfers on parasitemia (Figure 4A); a delay in
appearance of early parasitemia, and a reduction in peak
parasitemia. Mice receiving chronically stimulated memory T cells
(2CQ) showed a delayed onset of parasitemia (Figure 4A,l e f t
Figure 3. Heterogeneity of cytokine production and differentiation potential of the memory CD4
+ T-cell subsets in chronic P.
chabaudi infection. A) and B) Naı ¨ve (CD44
loCD25
2), CFSE-labelled B5 T cells (2610
6) were seeded into congenic Thy1.1
+ mice to follow the antigen-
specific cytokine response in memory cell subsets. Mice were infected with 10
5 P. chabaudi infected RBC and CD4
+ T cells analyzed 60 days later.
Divided B5 cells (CD44
hi CFSE
neg) were analyzed for A) expression of CD27 and CD62L to identify memory T cell subsets (Tcm, CD62L
hiCD27
+),
(Tem
early (TemE), CD62L
loCD27
+) and (Tem
late (TemL), CD62L
loCD27
2) and production of IL-10 and IFN-c in each subset. B) Divided B5 T cells
(CFSE
neg) were analyzed for CD44 and CD62L to identify Tem (CD44
hiCD62L
lo) and Tcm (CD44
hiCD62L
hi) and production of IL-2 and TNF-a. These
data are representative of 5 individual mice. C) and D) Purified memory T cell subsets (CD4
+CD44
hiIL-7Ra
+); Tcm, (CD62L
hiCD27
+), (TemE,
CD62L
loCD27
+) and (TemL, CD62L
loCD27
+) were transferred (10
5) into RAGu mice which were then infected with P. chabaudi. Spleens were analysed
on day 38 after infection by multi-parameter FACS analysis; C) memory cell composition on recovery, Tcm, TemE and TemL, as defined in A), of CD4
+
T cells, shown as percentage of lymphocytes; D) Proposed linear differentiation pathway for memory T cell subsets based on the data in C).
doi:10.1371/journal.ppat.1001208.g003
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early parasite growth. Consistent with this, chronically stimulated
memory T cells also reduced peak parasitemia (p=0.02) compared
with resting cells, (Figure 4A, right graph) or naı ¨ve cells (data not
shown). Consistent with reduced parasitemia, mice receiving
chronically stimulated cells exhibited less pathology than mice
receiving rested memory T cells (Figure 4B) and naı ¨ve cells (not
shown).Thuschronicallystimulated malaria-specificmemoryT cells
show an enhanced early protective effect with reduced parasitemias
and reduced pathology compared with rested memory T cells.
Furthermore, chronically stimulated B5 memory T cells provided
more effective help for a P. chabaudi-specific antibody response than
resting memory B5 cells (Figure 4B). RAGu mice receiving
chronically stimulated T cells also had higher levels of TNFa,
IFN-c and IL-10, in plasma at day 7 of infection (Figure 4C), than
those receiving rested T cells. These inflammatory cytokines may
enhance parasite killing, while IL-10, may regulate their pathogenic
effects, as has been described previously [35].
Figure 4. Chronically stimulated memory T cells protect immunodeficient mice from parasitemia and pathology better than rested
memory T cells. MSP1-specific CD4
+ B5 memory (CD44
hi) or naı ¨ve (CD44
lowCD25
2) T cells were purified from B5 TCR Tg mice infected 2.5 months
previously and harbouring a chronic infection (2CQ, closed symbol/bar), or drug treated from days 30–34 to remove the chronic infection (+CQ,
open symbol/bar). The cells (10
5) were transferred into RAGu recipients together with immune B cells (10
7) and the recipients infected with 5610
4 P.
chabaudi iRBC. A) Parasitemia (geometric mean +/2SEM) is at onset of patent parasitemia (day 6, left graph), and at peak parasitemia (days 8 and 10,
middle graph) B) Peak weight change is shown as a measure of cachexia (left graph), maximum loss of body temperature (middle graph) and
P.chabaudi -specific IgG antibodies (day 21) measured in the serum of the transferred RAGu animals by ELISA. C) Serum IL-10, IFN-c, and TNFa were
measured on day 7 in RAGu mice receiving Tg cells from chronically infected (closed symbols) or drug-treated mice (open symbols). The data shown
are the means and SEM of 4–7 mice.
doi:10.1371/journal.ppat.1001208.g004
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cytokines than rested memory cells
As we have shown that the more protective chronically
stimulated memory T cells resulted in larger amounts of
circulating cytokines upon adoptive transfer into RAGu mice than
rested memory T cells, we investigated whether this was also the
case in the chronic infection itself, which might explain the greater
protective efficacy of the chronically stimulated T cells. Memory
cells making multiple cytokines have been proposed to correlate
with the protectiveness of vaccines and the effectiveness of memory
cells in various chronic infections that require T cells for clearance
of the pathogen [36].
In line with the more rapid effect on parasitemia after adoptive
transfer, there was a larger population of IL-7Ra
2 effector T cells
(Teff) in the chronically infected mice (Figure 5A, p=0.038)
compared with CQ-treated mice. Conversely, there was a
significantly greater proportion of IL-7Ra
+CD44
hi memory T
cells in the B5 CD4
+ T cell population from CQ-treated mice
(+CQ, Figure 5A, p=0.0073). The increase of effector cells in
chronically infected mice and the decrease in memory T cells was
also seen in the endogenous CD4
+ population (Figure S8). We
could not detect any reproducible differences in the activation
markers of effector cells (as defined in Figure 1) between
chronically stimulated and ‘‘rested’’ memory Tg CD4 T cells,
nor in the composition of the memory cell subsets (as defined in
Figure 2C).
To determine whether the proportion of memory T cells
making multiple cytokines in P. chabaudi was different in
chronically stimulated and ‘‘rested’’ Tg CD4 T cells, we compared
their intracellular cytokine profiles on day 60 post-infection, as
described above for Figure 3. Chronically stimulated (2CQ) Tg
CD4 T cells at day 60 contained a higher proportion of cells
producing both TNF and IFN-c but not IL-2 than memory cells
from drug-treated mice (Figure 5B, Figure 5C). The propor-
tions of triple cytokine producing cells however were not
significantly different (Figure 5C, left). The difference in the
double-producing cells was mainly within the CD62L
loCD44
hi
effector or effector memory cell population (Figure 5D). Our data
suggest that the greater capacity of CD4
+ T cells in chronic
infection to control early parasitemia is due to the maintenance of
Th1 effector cytokine potential by the effector or effector memory
cells.
Discussion
There is a real need to understand protective immune
mechanisms in malaria in order to improve vaccination.
Development of immunological memory to malaria infection
develops over several exposures, and protection is short-lived in
the absence of exposure to the parasite [37]. CD4
+ T cell
responses and specifically CD4
+ T cell memory, which are of
central importance in immunity to blood-stage Plasmodium
infections, have been comparatively little investigated in infections
in vivo, compared with CD8
+ T cell responses to the liver stages of
malaria [38], despite the fact that it is the blood stages and CD4
+
cells which cause disease.
Here, we have used a mouse model of malaria, P. chabaudi,t o
investigate whether Plasmodium-specific CD4
+ T cell memory
develops in a blood-stage infection. We show that CD4
+ T cells
with phenotypic characteristics of memory cells are indeed
generated within two months of an infection. They develop
slowly, and the predominant memory cells are early effector
memory cells, the majority of which are able to produce cytokines
on short-term re-stimulation and to become effector cells on re-
infection. Importantly, we showed that chronically stimulated
memory T cells protect immunocompromised mice from infection
better than rested memory cells.
There was a striking predominance of CD4
+CD62L
lo effector
memory cells remaining after the acute P. chabaudi infection, which
remained in a relatively activated state. Such cells have also been
shown to predominate in the liver stages of malaria [15,39] and
are present in humans protected against malaria by P. falciparum
sporozoite challenge [40] as well as in other chronic infections
such as LCMV [26], T. cruzi [13,14] T. muris [41], gamma herpes
virus [42], and human Hepatitis B and C [43], and in some cases
are critically important in effector sites such as the lung [44,45,46].
The type of memory cells maintained may depend on
persistence of specific or non-specific stimulation. Studies of
CD8+ T cell memory in human viral infections have correlated
memory phenotypes with the level of chronic infection [19], and
suggested that memory T cell differentiation progresses through a
maturation process dependant on the level and duration of
antigenic stimulation [17,18,47]. Thus a linear pathway of
differentiation (Tcm.TemE.TemL) has been proposed based
on surface markers and the length of the telomeres in each subset;
where low level chronic infections would lead to maintenance of
early effector memory cells, but high levels would enhance late
effector memory [18]. Here we show conclusively that in chronic
infection central memory CD4+ T cells can produce these other
two subsets that are indeed related in a linear manner to one
another as suggested by the human studies as well as effector T
cells. It is likely that selection for high affinity clones and regulation
of cytokine production [48] occurs during this differentiation
process.
Both Teff and Tem CD4 T cells can protect in various
infectious disease models [12,16,28,41,49], and for CD8 T cells, in
some cases, they are more potent than resting memory cells
[41,50,51]. Although effector memory cells are likely to be more
short-lived than central memory cells [52], there are other reports
of long-term persistence of effector-type cells [53]. From our
studies it appears that CD4
+ Tem survive the acute infection,
especially CD27
+ cells. This molecule, a member of TNFR family,
has been shown to prolong the life of T cells [54]. Extrapolating
these findings to human Plasmodium infections, it is possible that
TemE may survive and protect for extended periods after an
infection.
We compared memory CD4 T cells generated and maintained
in chronic infection, with those that survived after drug-clearance
of infection. We identified an increase in CD44
hiIL-7Ra
+ memory
CD4 T cells after drug treatment. Although IL-7 can be utilized by
memory T cells for survival [55], the observation that in
chronically infected mice there were more IL-7Ra
2 effector cells
two months after infection suggests that a sub-population in
infected mice may depend instead on antigen or infection for
maintenance.
In an adoptive transfer and infection system, chronically
stimulated memory CD4
+ T cells were more protective; they
slowed parasite growth, reduced peak parasitemia and were
associated with less pathology compared with resting memory cells
obtained from infected and drug-cured mice. Despite the eventual
higher antibody titers in mice receiving chronically stimulated
CD4
+ T cells, it is unlikely that antibody was the mechanism of
parasite control, as at this early stage of infection anti-malaria
antibodies were not detectable. However, the chronically stimu-
lated CD4
+ T cells contained more effector cells and a greater
proportion of TNFa
+IFN-c
+IL2
2 double-producing cells than
resting memory cells. Furthermore, mice receiving the chronically
stimulated CD4
+ T cells had significantly greater plasma levels of
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control [56]. Together, our data suggest that Th1 memory cells
can control the acute P. chabaudi parasitemia. It will be important
to determine which of the activated memory cell subsets [17,28]
within the chronically activated T cell population containing the
IFN-c
+TNFa
+IL2
2 cells are responsible for these anti-parasite
effects. The lesser pathology observed in mice receiving chroni-
cally stimulated memory T cells compared with rested memory
cells, may be the result of the lower parasitemia brought about
through the effects of TNFa and IFN-c, and to the increased levels
of IL-10, a cytokine known to down-regulate pathology associated
with P. chabaudi infections [35].
Here we have seen that the changes in a memory population on
withdrawal of infectious stimuli for a month after infection, have
Figure 5. Treatment of a chronic P. chabaudi infection changes the phenotype of memory cells and their cytokine profiles towards
Th1 late effector profile. CD4
+ MSP1-specific B5 Tg T cells were seeded into Thy1.1 congenic mice to follow the antigen-specific response. Mice
were infected with 10
5 Plasmodium chabaudi and treated with Chloroquine (CQ) during days 30–34 to clear the chronic infection. Splenocytes were
analyzed by flow cytometry on day 60 post-infection, and the FACS plots were gated on Thy1.2
+CD4
+ cells. A) Differences in the proportions of
Tmem, (CD44
hi IL-7Ra
+), and effector (Teff, CD44
hi IL-7Ra
2) cells at day 60 between mice treated and not treated with chloroquine (+CQ and 2CQ
respectively). The percentage of IL-7Ra
+ Tmem or IL-7Ra
2 Teff within the CD44
hi cell population is shown as a graph (right). These differences were
observed in 4 independent experiments. B) IFN-c and TNFa production in Thy1.2
+CD4+ CD44
hiCD62L
lo B5 cells from chloroquine-treated and -
untreated mice at day 60 post infection. C) Multiple cytokine producing B5 CD4 T cells from chloroquine-treated and untreated mice at day 60 post-
infection. Percent double-producing TNFa
+IFN-c
+IL-2
2 and triple-producing IFN-c
+TNFa
+IL-2
+ are shown. D) IFNc
+ TNFa
+ (IL-2
2) double producing
cells within the Tem subset of B5 at 60 days post-infection. The graphs show means and SEM from 5 mice. ** p#.01 and * p#.05 by student’s t-test.
doi:10.1371/journal.ppat.1001208.g005
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subsets in the spleen in P. chabaudi malaria, but nevertheless reduce
the potential for Th1 cytokine production, and protection. Our
data suggest that chronically stimulated memory CD4
+ T cells are
the most protective for controlling early parasitemia and
pathology, as seen in Leishmania infections, another low-level
chronic infection. However Tem may be short-lived, as they are
not thought to be the main component of long-lived memory [57].
This might explain why protective memory is lost in mice over
time [5] and in humans who move away from endemic areas [3],
as previously activated cells revert to a resting state [11]. A
contribution of continually stimulated effector memory CD4
+ T
cells to parasite control and regulation of pathology are very much
in line with observations that the best protection of humans in
areas of endemic malaria is a certain level of continuous exposure
[2,37], and with the association of effector memory cells producing
multiple cytokines observed in humans experimentally infected
with P. falciparum sporozoites [40]. This suggests that vaccination
methods that enhance production, and survival of cells which
maintain effector functions, may be the most successful in
protection against severe malaria, although this must be balanced
with the well-tuned production of regulatory cytokines.
Methods
Mice and parasites
Female BALB/c (MRC strain) were maintained in the breeding
facilities of the MRC National Institute of Medical Research.
BALB/c rag22/2 mice (RAGu) were a gift from Dr Anton Rolink
(University of Basel, Basel, Switzerland). Thy1.1 BALB/c congenic
mice (N=15 BALB/c) were a kind gift of Dr. David Tough, (Jenner
Institute, Compton, UK) and were further backcrossed four
generations to BALB/c (MRC) for adoptive transfers. B5 TCR
Transgenic mice were generated as described [25]. The B5 TCR
recognizes MSP1 (1157–1171, ISVLKSRLLKRKKYI/I-E
d); B5
TCR Tg mice were typed using correct primers Va2, gaacgttcca-
gattccatgg and atggacaagatcctgacagcatcg; and Vb8.1, cagagaccct-
caggcggctgctcagg and atgggctccaggctgttctttgtggttttgattc.
Mice, 5–8 weeks, were infected with 10
5 P. chabaudi chabaudi (AS)–
infected erythrocytes i.p. and monitored by Giemsa-stained blood
films [22]. The presence of sub-patent chronic parasitemias were
determined by subinoculation of blood into naı ¨ve recipient mice at
various times during the chronic infection as described [6]. To
eliminate chronic infections, mice were treated three times with
50mg/kg Chloroquine (Sigma, Dorset, UK) in saline (Sigma)
alternate days between days 30–34. P. chabaudi (AS) is sensitive to
chloroquine at low parasite density, as on day 30 post-infection [6].
Weight (g) was measured on a balance and percent change was
calculated as: ((weight - d0 wt)/d0 wt)6100%. Temperature change
was recorded from subcutaneously implanted transponders on
BioMedic Data Systems DAS5002 (PLEXX, Elst, Netherlands).
Ethical statement
All animal experiments were carried out according to UK
National guidelines (Scientific Procedures) Act 1986 under licence
PPL80/2385 approved by the British Home Office. The
procedures used were approved by the NIMR institutional Ethical
Review Panel.
Flow cytometry
Single-cell suspensions of spleen, liver and lymph nodes were
made in HBSS, incubated in red blood cell lysis buffer (Sigma),
and stained in PBS 2% FBS (PAA Laboratories, Somerset, UK)
and 0.1% sodium azide with anti-CD16/32 (24G2) supernatant
followed by combinations of FITC–, PE–, PE-TexasRed,
peridinin chlorophyll protein (PerCP), PE/Cyanine 7 (Cy7),
Pacific Blue (PB), biotin- (-b-), allophycocyanin (APC)–, or APC/
Cy7-conjugated antibodies: CD4 (RM4-5, BD Biosciences, Cam-
bridge Biosciences Oxford, UK) or CD127-PE, CD90.2-
eFluor450, -PE/C7 (A47E, 53-2.1 eBiosciences, Hatfield, UK)
or CD43-PE/Cy7 (1B11 Biolegend/Cambridge Bioscience, Cam-
bridge, UK) or CD4-Pacific Orange (PO, Caltag, Invitrogen
Paisley, Scotland). The second-step reagents streptavidin-PerCP;
(BDbiosciences) and strepdavidin-PB (Invitrogen) were used. For
intracellular cytokine staining, cells were pre-treated for one hour
with 80–100uM TAPI-2 (Peptides International) [33], and then
stimulated for 5h in complete Iscove’s medium (cIMDM, Sigma),
10% FBS, 2 mM L-glutamine, 0.5 mM sodium pyruvate, 100 U
penicillin, 100 mg streptomycin, and 50 mM 2-ME (Gibco,
Invitrogen) with PMA (50 ng/mL; Sigma), ionomycin (500 ng/
mL; Sigma), and BrefeldinA (10 mg/mL; Sigma) for the last two
hours. Cells were fixed in 2% paraformaldehyde 20 minutes, and
resuspended in staining buffer overnight. Permeabilized in Perm/
Wash buffer (BDbiosciences) 25 minutes and washed twice, then
incubated for 40 minutes with anti–IFNc-PE (XMG1.2), IL2-APC
(JES6-5H4), TNFa (MP6-XT22), IL10-APC (JES5-16E3; all from
BD Biosciences). Cells were washed thrice in Perm/Wash and
resuspended in staining buffer. Cells were collected on a
FACSCalibur or 9-color CyAn ADP (DAKO, Beckman Coulter)
using Summit software (Cytomation) and analyzed in FlowJo (Tree
Star, Ashland, OR). Staining combinations were designed through
a meticulous optimization strategy as described by Seder et al and
Tung et al [36,58]. Compensation was performed in Flow Jo using
single stained splenocytes or bead controls (BD CompBeads Anti-
Rat Ig, k) and results thoroughly checked for accuracy and
consistency. For presentation, data from 2–5 mice is concatenated
to achieve sufficient cell numbers (5–10,000) for presentation and
Boolean gating analysis, only after each mouse was carefully
analyzed and averages and standard errors of the mean (SEM)
calculated.
For in vitro stimulation, naı ¨ve cell transfers, and RAGu transfers,
B5 Tg CD4
+ cells were purified by positive selection with magnetic
micro-beads (Miltenyi Biotec, Surrey, UK) using magnetic-
activated cell sorting (autoMACS) and further purified as naı ¨ve
(CD44
lo, CD25
2) or memory (CD44
hi) T cells by high speed
(MoFlo, Cytomation, Beckman Coulter) sorting to .99% purity.
In naı ¨ve cell transfers, cells were labeled for 10 min at 37uC with
1mM CFSE (Molecular Probes, Invitrogen) after washing thrice in
cation-free PBS. Memory subsets were purified on a FACS Aria
(BDbiosciences) as shown in Figure S4, as CD44
hi IL-7Ra
+, and
Tcm, CD62L
hi CD27
+; TemE, CD62L
lo CD27
+; and TemL,
CD62L
lo CD27
2 to about 95% purity.
Adoptive transfers
Splenic CD4
+ T and CD19
+ B cells were purified by MACS
(95% purity, Miltenyi). B5 Tg CD4
+ T cells were transferred
(2610
6) into uninfected congenic Thy1.1 BALB/c mice. To
determine presence of B5 antigen, CFSE-labeled CD4
+ B5 T cells
were transferred into previously infected mice for 4–5 days.
Immune B cells were generated by infecting BALB/c mice with
10
5 P. chabaudi twice, 2 months apart. In RAGu transfer, 10
5 naı ¨ve,
memory, or memory subsets T cells and 10
7 B cells were sort-
purified (MoFlo, cytomation) and transferred. Reconstitution was
analyzed day 39 post infection and all mice had 3.5–28% (of
lymphocyte gate) T cells (naı ¨ve T cells average 19.562.4%, Tmem
average 1161.0%) and 0.8–5.3% B cells in the spleen (average
2.360.2%). One mouse with less than 0.5% of both B and T cells,
and excessive splenomegaly was excluded from the study.
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IL-10, TNF and IFN-c were measured in serum from animals
at day 7 post-infection using the Luminex Flexible Beadlyte
Immunoassay (BioRad or Upstate/Millipore, Milton Keynes,
UK), according to the manufacturers instructions. Plates were read
and analyzed using the Luminex 100 machine and software
(Upstate).
Malaria-specific ELISA
Malaria-specific antibodies were measured by ELISA, as
described. Plates were coated with a soluble fraction of the lysate
of P. chabaudi blood-stage parasites, IgG was detected using
alkaline-phosphatase linked secondary antibody (Southern Bio-
tech, Cambridge, UK) and PNPP substrate (Sigma). Results are
expressed as relative units based on a standard hyperimmune
plasma (all described in [59]).
Statistics
Statistics were performed in Prism (GraphPad, La Jolla, CA)
using Student t-test, with P#.05 was considered significant.
Supporting Information
Figure S1 CD44 gating is shown clearly as correlating with
division, as shown in A) which is gated on Thy1.2
+CD4
+ cells. B)
CD4
+ cells show a double peak for CD44 staining (red), while
CFSE
+ B5 Tg cells are uniformly CD44
hi (blue) and CFSE
neg B5
Tg cells are CD44
lo (green). The CD44 gate was set using this type
of analysis for each sample.
Found at: doi:10.1371/journal.ppat.1001208.s001 (0.19 MB TIF)
Figure S2 As few as 5,000 CD4+ naive-purified CFSE-labeled
B5 TCR Tg T cells were transferred into Thy1.1 congenic mice,
which were infected with 10
5 P. chabaudi. B5 T cells were identified
after MACS enrichment of Thy1.2
+ cells by using a high-
sensitivity double labeling approach. The technique is specific as
evidenced by the CFSE labeling of the identified Thy1.2
+ B5 cells
on day 6. A) On day 6 post-infection (pi) with transfers of 5610
4,
Teff were generated in the spleen, but not in the lymph nodes. B)
On day 60 pi as few as 5,000 cells were still detectable by this
method and seem to have a similar phenotype as when 2610
6 are
transferred, as in the main figures. B5 Tg cells collected from two
mice were concatenated to make these plots. More cells divided
when fewer were transferred, as previously reported. Cells were
not detectable, even using this high-sensitivity double fluoro-
chrome labeling, without infection (1610
6 uninf), at day 60 pi.
Found at: doi:10.1371/journal.ppat.1001208.s002 (0.46 MB TIF)
Figure S3 Effector CD4+ T cells persist in P. chabaudi infection
and early effector memory cells predominate. Naı ¨ve
(CD44
loCD25
2), CFSE-labeled B5 T cells (2610
6) were seeded
into congenic Thy1.1 mice, which were then infected with 10
5 P.
chabaudi iRBC. (Top) CD44
hiIL-7Ra(CD127)
+ memory cells are
shown in the divided CFSE
neg population. (Bottom) Tmem were
subdivided using CD62L and CD27 to measure central (Tcm,
CD62L
hiCD27
+), and early effector memory cells (TemE,
CD62L
loCD27
+) as well as CD27
2 late effector memory T cells
(TemL, CD62L
loCD27
2) shown here at day 60 of infection. These
are the plots that were concatenated to show CD4
+Thy1.2
+CFSE-
neg cells on day 60 post-infection in Figure 2. Gated as shown in
Figure1A).Mouse2wasnotincludedinfurtheranalysisduetopoor
recovery. Experiment was repeated three times with similar results.
Found at: doi:10.1371/journal.ppat.1001208.s003 (0.71 MB TIF)
FigureS4 By d45 Tem predominate in liver and are also present in
lymph nodes A) Naive sorted CD4
+CD44
loCD25
2 B5 T cells were
transferred (2610
6) into congenic Thy1.1 recipients, which were then
infected. Divided B5 cells (CD4
+Thy1.2
+CFSE
neg) are analyzed for
CD44, CD62L and IL-7Ra to observe effector cell kinetics with
percentages of Tmem (CD44
hi IL-7Ra
+), Teff (CD62L
lo IL-7Ra
2),
Tcm (CD44
hiCD62L
hi), Tem (CD44
hiCD62L
lo, includes some Teff)
in the A) Liver or B) peripheral lymph nodes (pooled). Data
represents concatenated total B5 cells from 2–5 mice (.1000 cells/
timepoint).
Found at: doi:10.1371/journal.ppat.1001208.s004 (0.12 MB TIF)
Figure S5 Non-transgenic and B5 transgenic effector CD4
+ T
cells persist in P. chabaudi infection. BALB/c or B5 TCR Tg mice
were infected with 10
5 P. chabaudi iRBC and were analyzed for the
presence of effector and memory T cells throughout infection. A)
IL-7Ra
2CD62L
lo effector cells and B) CD44
hiIL-7Ra
+ memory
cells are shown in the CD4
+ population. The kinetics of effector
cell and memory cell generation is remarkably similar in these two
strains of mice validating the use of MSP-1 specific B5 Tg memory
cells for differentiation experiments.
Found at: doi:10.1371/journal.ppat.1001208.s005 (0.68 MB TIF)
Figure S6 B5 TCR Tg CD4+ cells were MACS purified to
.90% purity, then purified on a BDFACSAria as CD44
hi IL-
7Ra+ memory cells and Tcm (CD27
+CD62L
hi), TemEarly
(CD27
+CD62L
lo) and TemLate (CD27
2CD62L
lo) for RAG
transfer in Figure 4.
Found at: doi:10.1371/journal.ppat.1001208.s006 (0.64 MB TIF)
Figure S7 Chloroquine treatment of chronic infection reduces
available T cell antigen and protection. A) BALB/c mice were
infected with 10
5 P. chabaudi-iRBC and treated days 30–34 with
Chloroquine (CQ) to clear the persistent infection. Some mice
were re-infected at day 45 (10
5 parasites). Parasitemia was
measured as % parasitized RBC/total RBC. B) To detect antigen
availability in previously infected mice CFSE labeled B5 Tg CD4
+
T cells were transferred for 4 days into mice infected 45 or 60 days
previously. Data are presented as the average of divided cells
(%CFSE
neg) from infected mice with background division in
paired, uninfected mice subtracted. Error bars represent SEM of 5
mice per group.
Found at: doi:10.1371/journal.ppat.1001208.s007 (0.11 MB
TIF)
Figure S8 Effector CD4+ T cells persist in chronic P. chabaudi
infection. Naı ¨ve (CD44
loCD25-), CFSE-labeled B5 T cells (2610
6)
were seeded into congenic Thy1.1
+ mice, which were then infected
with 10
5 P. chabaudi iRBC. CD44
hi IL-7Ra
+ memory cells are
shown and effector cells (IL-7Ra-) are shown here at day 60 of
infection in both the MSP-1 specific B5 transgenic cells and the
endogenous CD4+ T cells. 2CQ indicates no chloroquine
treatment, +CQ indicates treatment with chloroquine at day 30
to remove the chronic infection.
Found at: doi:10.1371/journal.ppat.1001208.s008 (0.15 MB TIF)
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